Limited infection upon human exposure to a recombinant raccoon pox vaccine vector

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2757-2760

  Rocke, Tonie E ^a   Dein, F Joshua ^a   Fuchsberger, Martina ^a   Fox, Barry C ^b   Stinchcomb, Dan T ^c   Osorio, Jorge E ^d  

^a NATIONAL WILDLIFE HEALTH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c HESKA CORPORATION   (United States)

^d PowderJect Vaccines   (United States)

Author keywords

Raccoon poxvirus; Viral vector; Yersinia pestis

Indexed keywords

ANTIBIOTIC AGENT; VIRUS VECTOR;

ADULT; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BACTERIUM CULTURE; BLISTER; BLOOD SAMPLING; CASE REPORT; CYTODIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; RACCOON; VIRUS CULTURE; VIRUS ISOLATION; VIRUS RECOMBINANT; YERSINIA PESTIS;

ACCIDENTS, OCCUPATIONAL; ADULT; ANIMALS; ANTIBODIES, VIRAL; FEMALE; GENETIC VECTORS; HUMANS; LABORATORIES; MICE; PLAGUE; POXVIRIDAE; POXVIRIDAE INFECTIONS; RACCOONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL VACCINES; YERSINIA PESTIS;

EID: 3142642826     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.030     Document Type: Article

References (14)

1. Eskey CR, Haas VH. Plague in the western part of the United States. US Public Health Bull 1940:254.
2. Menkens G.E., Anderson S.H. Population dynamics of white-tailed prairie dogs during an epizootic of sylvatic plague. J. Mammal. 72:1991;328-331
3. Doll J.M., Seitz P.S., Ettestad P., Bucholtz A.L., Davis T., Gage K. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 51:1994;109-114
4. Osorio J.E., Powell T.D., Frank R.S., Moss K., Haanes E.J., Smith S.R., et al. Recombinant raccoon pox vaccine protects mice against lethal plague. Vaccine. 21:2002;1232-1238
5. Wiktor T.J., MacFarlan R.I., Reagan K.J., Berhnahard D., Curtis P.J., Wunner W.H., et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA. 81:1984;7194-7198
6. Hanlon C.A., Niezgoda M., Hamir A.N., Schumacher C., Koprowski H., Rupprecht C.E. First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J. Wildl. Dis. 34:1998;228-239
7. Alexander A.D., Flyger V., Herman Y.F., McConnell S.J., Rothstein N., Yager R.H. Survey of wild mammals in a Chesapeake Bay area for selected zoonoses. J. Wildl. Dis. 8:1972;110-126
8. Hu L., Esposito J.J., Scott F.W. Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge. Virology. 218:1996;248-252
9. Esposito JJ, Sumner JW, Brown DR, Ebert JW, Shaddock JH, Bai XH, et al. Raccoon poxvirus rabies-glycoprotein recombinant oral vaccine for wildlife: further efficacy and safety studies and serosurvey for raccoon poxvirus. In: Brown F, Chanock RM, Ginsberg H, Lerner RA, editors. Vaccines-92: modern approaches to new vaccines including prevention of AIDS. New York: Cold Spring Harbor Laboratory Press; 1992. p. 321-30.
10. Ropp S.L., Jin Q., Knight J.C., Massung R.F., Esposito J.J. PCR strategy for identification and differentiation of smallpox and other orthopoxviruses. J. Clin. Microbiol. 33:1995;2069-2076
11. Openshaw P.J.M., Alwan W.H., Cherrie A.H., Record F.M. Accidental infection of a laboratory worker with recombinant vaccinia virus. Lancet. 31:1991;459
12. Redfield R.R., Wright D.C., James W.D., Jones T.S., Brown C., Burke D.S. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 316:1987;673-675
13. Rupprecht C.E., Blass L., Smith K., Orciari L.A., Niezgoda M., Whitfield S.G., et al. Human infection due to recombinant vaccinia-rabies glycoprotein virus. N. Engl. J. Med. 345:2001;582-586
14. Osorio JE, Frank R, Moss K, Taraska T, Powell T, Stinchcomb DT. Raccoon poxvirus as a mucosal vaccine vector for domestic cats. J Drug Target, in press.